home / stock / glpgf / glpgf message board
Subject | By | Source | When |
---|---|---|---|
Galapagos Genomics NV changed to Galapagos NV: | Renee | investorshub | 10/02/2015 8:59:30 PM |
Galapagos acquires structure-based drug discovery from Sareum | surf1944 | investorshub | 09/05/2008 1:13:36 AM |
UCB transfers UK-based medicinal chemistry program to BioFocus DPI | surf1944 | investorshub | 08/18/2008 4:01:00 PM |
Galapagos announces milestone payment of EUR 0.8 million | surf1944 | investorshub | 07/10/2008 2:40:55 PM |
Galapagos signs research agreement with UCL | surf1944 | investorshub | 06/03/2008 1:08:39 PM |
Bausch & Lomb and Galapagos sign agreement to | surf1944 | investorshub | 04/27/2008 5:25:38 PM |
Galapagos announces 2007 full year results | surf1944 | investorshub | 04/03/2008 2:52:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Galapagos Genomics Ord Company Name:
GLPGF Stock Symbol:
OTCMKTS Market:
Advanced potentially best-in-class cell therapy and small molecule R&D pipeline comprising four clinical assets and >15 discovery programs in oncology and immunology Executed agreements with BridGene Biosciences and Thermo Fisher Scientific, and investment in Frontier Medicines ...
Mechelen, Belgium; 30 April 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the company’s Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) held on 30 April 2024 were approved. The AGM approved, amongst...
Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen, Belgium; 4 April 2024, 22:01 CET – Galapagos NV (Euronext & NASDAQ...